These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1827 related articles for article (PubMed ID: 11687119)
61. Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease. Lilienfeld S CNS Drug Rev; 2002; 8(2):159-76. PubMed ID: 12177686 [TBL] [Abstract][Full Text] [Related]
62. Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease. Morris JC; Cyrus PA; Orazem J; Mas J; Bieber F; Ruzicka BB; Gulanski B Neurology; 1998 May; 50(5):1222-30. PubMed ID: 9595967 [TBL] [Abstract][Full Text] [Related]
63. Folic acid with or without vitamin B12 for cognition and dementia. Malouf M; Grimley EJ; Areosa SA Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018 [TBL] [Abstract][Full Text] [Related]
65. A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong. Chu LW; Yik PY; Mok W; Chung CP Int J Clin Pract; 2007 Mar; 61(3):403-10. PubMed ID: 17313606 [TBL] [Abstract][Full Text] [Related]
66. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. Tan CC; Yu JT; Wang HF; Tan MS; Meng XF; Wang C; Jiang T; Zhu XC; Tan L J Alzheimers Dis; 2014; 41(2):615-31. PubMed ID: 24662102 [TBL] [Abstract][Full Text] [Related]
67. Vitamin E for Alzheimer's dementia and mild cognitive impairment. Farina N; Llewellyn D; Isaac MGEKN; Tabet N Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002854. PubMed ID: 28418065 [TBL] [Abstract][Full Text] [Related]
72. Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease. Imbimbo BP CNS Drugs; 2001; 15(5):375-90. PubMed ID: 11475943 [TBL] [Abstract][Full Text] [Related]
73. Cholinesterase inhibitors for Parkinson's disease dementia. Maidment I; Fox C; Boustani M Cochrane Database Syst Rev; 2006 Jan; (1):CD004747. PubMed ID: 16437494 [TBL] [Abstract][Full Text] [Related]
74. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Erkinjuntti T; Kurz A; Gauthier S; Bullock R; Lilienfeld S; Damaraju CV Lancet; 2002 Apr; 359(9314):1283-90. PubMed ID: 11965273 [TBL] [Abstract][Full Text] [Related]
75. Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease. Small G; Erkinjuntti T; Kurz A; Lilienfeld S CNS Drugs; 2003; 17(12):905-14. PubMed ID: 12962529 [TBL] [Abstract][Full Text] [Related]